Specific features of lower urinary tract symptoms in men living in the moscow region. Results of the epidemiological study
- Authors: Pushkar D.Y.1, Rasner P.I1, Kotenko D.V1, Gerasimov A.N2, Shabalkin S.A1
-
Affiliations:
- A.I. Evdokimov MSUMD
- I.M. Sechenov First MSMU of Minzdrav of Russia (Sechenov University)
- Issue: No 3 (2018)
- Pages: 20-29
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/294364
- DOI: https://doi.org/10.18565/urology.2018.3.20-28
- ID: 294364
Cite item
Abstract
Keywords
Full Text
About the authors
D. Yu Pushkar
A.I. Evdokimov MSUMDCorr.-Member of the RAS, Dr.Med.Sci., Prof., Head of the Department of Urology, A.I. Evdokimov MSUMD, Chief Urologist of Minzdrav of Russia, Chief Urologist of Moscow
P. I Rasner
A.I. Evdokimov MSUMD
Email: dr.rasner@gmail.com
Dr.Med.Sci., Prof. at the Department of Urology, A.I. Evdokimov MSUMD, Head of the Department of Urology №4, S.I. Spasokukotsky Municipal Clinical Hospital of the Moscow HD
D. V Kotenko
A.I. Evdokimov MSUMDPh.D., Staff Member at the Department of Urology
A. N Gerasimov
I.M. Sechenov First MSMU of Minzdrav of Russia (Sechenov University)Dr. Phys.-Math. Sci., Professor, Head of the Department of Medical Informatics and Statistics, the Faculty of Medicine and Prevention
S. A Shabalkin
A.I. Evdokimov MSUMDStaff Member at the Department of Urology
References
- Пушкарь Д.Ю., Раснер П.И. Урология. Российские Клинические Рекомендации. Глава 1. Симптомы нижних мочевых путей и доброкачественная гиперплазия предстательной железы. Российские клинические рекомендации под ред. Ю.Г. Аляева, П.В. Глыбочко, Д.Ю. Пушкаря М.: МедФорум. 2018;13-43
- Вишневский А.Е., Пушкарь Д.Ю. Патогенез ноктурии у больных доброкачественной гиперплазией простаты. Клин, фармакология и терапия. 2005;2:45-48
- Irwin D.E., Milsom I., Hunskaar S., Reilly K., Kopp Z., Herschorn S., Coyne K., Kelleher C., Hampel C., Artibani W., Abrams P. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50(6):1306-1314.
- Milsom I., Abrams P., Cardozo L., Roberts R.G., Thüroff J., Wein A.J. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int. 2001;87(9):760- 766.
- Montorsi F., Roehrborn C., Garcia-Penit J., Borre M., Roeleveld T.A., Alimi J.C., Gagnier P., Wilson T.H. The effects of dutasteride or tamsulosin alone and in combination on storage and voiding symptoms in men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH): 4-year data from the Combination of Avodart and Tamsulosin (CombAT) study. BJU Int. 2011;107(9):1426-1431.
- Казилов Ю.Б., Гаджиева З.К., Мугутдинов Т.М., Казилов Б.Р. Распространенность различных нарушений мочеиспускания у жителей Республики Дагестан. Урология. 2016;4:42-47
- Пушкарь Д.Ю., Раснер П.И., Цуканов А.Ю., Куприянов Ю.А., Калашян А.А. Исследование знаний пациентов по выявлению рака простаты. Урология. 2010;2:48-52
- Malmsten U.G., Milsom I., Molander U., Norlen L.J. Urinary incontinence and lower urinary tract symptoms: an epidemiological study of men aged 45 to 99 years. J Urol. 1997;158:1733-1737.
- Rhodes T., Girman C.J., Jacobson D.J et al. Longitudinal prostate volume in a community-based sample: 7-year follow-up in the Olmsted County study of urinary symptoms and health status among men. J Urol. 2000;163:248, A1105.
- Jacobsen S.J., Jacobson D.J., Girman C.J., Roberts R.O., Rhodes T., Guess H.A., Lieber M.M. Natural History of Prostatism: Risk Factors for Acute Urinary Retention. The Journal of Urology. 1997;158(2):481-487.
- Jacobsen S.J., Jacobson D.J., Girman C.J., Roberts R.O., RhodesT., Guess H.A., Lieber M.M. Treatment for benign prostatic hyperplasia among community dwelling men: the Olmsted County study of urinary symptoms and health status. J Urol. 1999;162(4):1301-1306.
- Jacobsen S.J., Jacobson D.J., McGree M.E., St Sauver J.L., Klee G.G., Girman C.J., Lieber M.M. Sixteen-year Longitudinal Changes in Serum Prostate-specific Antigen Levels: the Olmsted County Study. Mayo Clin Proc. 2012;87(1):34-40.
- Shi-Jun Zhang, Hai-Ning Qian, Yan Zhao, Kai Sun, Hui-Qing Wang, Guo-Qing Liang, Feng-Hua Li, Zheng Li. Relationship between age and prostate size. Asian Journal ofAndrology. 2013;15:116-120.
- Berges R., Oelke M. Age-stratified normal values for prostate volume, PSA, maximum urinary flow rate, IPSS, and other LUTS/BPH indicators in the German male community-dwelling population aged 50 years or older. World J Urol. 2011;29(2):171-178.
- McConnell J.D., Roehrborn C.G., Bautista O.M., Andriole G.L. Jr., Dixon C.M., Kusek J.W., Lepor H., McVary K.T., Nyberg L.M. Jr., Clarke H.S., Crawford E.D., Diokno A., Foley J.P., Foster H.E., Jacobs S.C., Kaplan S.A., Kreder K.J., Lieber M.M., Lucia M.S., Miller G.J., Menon M., Milam D.F., Ramsdell J.W., Schenkman N.S., Slawin K.M., Smith J.A. The Long-Term Effect of Doxazosin, Finasteride and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia. N Engl J Med. 2003;349(25):2387-2398.
- Marberger M. The MTOPS Study: New Findings, New Insights, and Clinical Implications for the Management of BPH. Eur Urol. 2006;5:628-633.
- De Nunzio C., Aronson W., Freedland S.J., Giovannucci E., Parsons J. The correlation between metabolic syndrome and prostatic diseases. Eur Urol. 2012;61(3):560-570.
- Moul S., Mc Vary K.T. Lower urinary tract symptoms, obesity and the metabolic syndrome. Curr Opin Urol. 2010;20:7-12.
- Ogden C.L., Carroll M.D., Fryar C.D., Flegal K.M. Prevalence of Obesity Among Adults and Youth: United States, 2011-2014. NCHS Data Brief. 2015;(219):1-8.